A recent study in Nature Medicine pinpoints sources of ozone pollution and its deadly health impacts across Europe, highlighting the need for coordinated international efforts to reduce ozone levels and related mortality rates.
Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced